EFFECT OF SPIRAPRIL ON LEFT-VENTRICULAR HYPERTROPHY DUE TO VOLUME OVERLOAD IN RATS

被引:18
作者
UMEMURA, K [1 ]
ZIERHUT, W [1 ]
RUDIN, M [1 ]
NOVOSEL, D [1 ]
ROBERTSON, E [1 ]
PEDERSEN, B [1 ]
HOF, RP [1 ]
机构
[1] SANDOZ PHARMA LTD,PRECLIN RES,386 416,CH-4002 BASEL,SWITZERLAND
关键词
ANGIOTENSIN-CONVERTING ENZYME INHIBITOR; CARDIAC HYPERTROPHY; MAGNETIC RESONANCE IMAGING;
D O I
10.1097/00005344-199203000-00012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of the angiotensin-converting enzyme (ACE) inhibitor spirapril on structural and functional parameters of volume-overloaded rat hearts was evaluated in a time-course study. Left ventricular hypertrophy (LVH) was induced by graded disruption of the aortic valve in male Wistar rats. Four weeks later, structural (LV mass and LV wall thickness) as well as functional parameters [LV end-systolic and end-diastolic volumes, stroke volume (SV), ejection fraction (EF)] were determined in anesthetized animals by magnetic resonance imaging (MRI). The rats were then divided into two groups, one of them receiving spirapril (10 mg/kg/day) in food. LV parameters were evaluated by MRI at 4, 18, 25, and 32 days after treatment was started. MRI analysis before the start of treatment showed that both groups had developed a similar degree of eccentric LV hypertrophy. Similarly, LV wall thickness, end-systolic and end-diastolic volumes, SV, and EF did not differ between the groups. Treatment with spirapril resulted in stable LV weight during the follow-up period of 32 days, whereas the untreated group showed a significant steady increase in heart weight. LV end-diastolic volume, LV end-systolic volume, and SV were smaller in the spirapril group when measured after 25 and 32 days, but only the difference in end-diastolic volume reached statistical significance. LV wall thickness and EF were not affected by spirapril. After the last MRI determinations, blood pressure (BP) and the response to angiotensin I (ANGI) were measured in conscious animals. Systolic BP (SBP) and mean arterial pressure (MAP) were significantly lower in spirapril-treated rats, and the dose-response curve to ANGI was shifted to the right. The calculated end-systolic wall tension was considerably lower in the spirapril group. In conclusion, spirapril significantly reduced LV weight and end-diastolic volume in this model. The reduction in afterload observed in the spirapril group may have been the main contributor to this effect, although other mechanisms cannot be excluded by this study.
引用
收藏
页码:375 / 381
页数:7
相关论文
共 50 条
  • [21] PREVALENCE OF LEFT-VENTRICULAR HYPERTROPHY IN ELDERLY PATIENTS WITH WELL CONTROLLED HYPERTENSION
    JONES, E
    MORGAN, TO
    CALIFIORE, P
    JOHNS, J
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1990, 17 (03) : 207 - 210
  • [22] Nifedipine Inhibits Cardiac Hypertrophy and Left Ventricular Dysfunction in Response to Pressure Overload
    Ago, Tetsuro
    Yang, Yanfei
    Zhai, Peiyong
    Sadoshima, Junichi
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2010, 3 (04) : 304 - 313
  • [23] Nifedipine Inhibits Cardiac Hypertrophy and Left Ventricular Dysfunction in Response to Pressure Overload
    Tetsuro Ago
    Yanfei Yang
    Peiyong Zhai
    Junichi Sadoshima
    Journal of Cardiovascular Translational Research, 2010, 3 : 304 - 313
  • [24] REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY BY ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR IN REDUCED RENAL MASS HYPERTENSIVE RATS
    NAKAMURA, F
    NAGANO, M
    HIGAKI, J
    HIGASHIMORI, K
    KATAHIRA, K
    MORISHITA, R
    MIKAMI, H
    OGIHARA, T
    JOURNAL OF HYPERTENSION, 1991, 9 : S398 - S399
  • [25] Effect of renal denervation procedure on left ventricular hypertrophy of hypertensive rats and its mechanisms
    Jiang, Weihong
    Tan, Lihua
    Guo, Yunzhong
    Li, Xiaogang
    Tang, Xiaohong
    Yang, Kan
    ACTA CIRURGICA BRASILEIRA, 2012, 27 (11) : 815 - 820
  • [26] EFFECT OF LEFT-VENTRICULAR HYPERTROPHY SECONDARY TO CHRONIC PRESSURE-OVERLOAD ON TRANSMURAL MYOCARDIAL 2-DEOXYGLUCOSE UPTAKE - A P-31 NMR SPECTROSCOPIC STUDY
    ZHANG, JY
    DUNCKER, DJ
    YA, X
    ZHANG, Y
    PAVEK, T
    WEI, H
    MERKLE, H
    UGURBIL, K
    FROM, AHL
    BACHE, RJ
    CIRCULATION, 1995, 92 (05) : 1274 - 1283
  • [27] An antidiabetic thiazolidinedione induces eccentric cardiac hypertrophy by cardiac volume overload in rats
    Arakawa, K
    Ishihara, T
    Aoto, M
    Inamasu, M
    Kitamura, K
    Saito, A
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (1-2): : 8 - 13
  • [28] Left Ventricular Hypertrophy is Prevalent in Sprague-Dawley Rats
    Clifford, Charles B.
    Pritchett-Corning, Kathleen
    Mulder, Guy B.
    COMPARATIVE MEDICINE, 2011, 61 (01) : 11 - 12
  • [29] REVERSAL OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS - A METAANALYSIS OF 109 TREATMENT STUDIES
    DAHLOF, B
    PENNERT, K
    HANSSON, L
    AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (02) : 95 - 110
  • [30] INVOLVEMENT OF THE RENIN-ANGIOTENSIN SYSTEM IN THE DEVELOPMENT OF LEFT-VENTRICULAR HYPERTROPHY AND DYSFUNCTION
    YAMAZAKI, T
    SHIOJIMA, I
    KOMURO, I
    NAGAI, R
    YAZAKI, Y
    JOURNAL OF HYPERTENSION, 1994, 12 : S23 - S27